These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32522096)

  • 21. Inhibitory effect of intravitreal injection of bevacizumab on nerve growth factor.
    Jee D; Lee WK
    Curr Eye Res; 2012 May; 37(5):408-15. PubMed ID: 22040304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis.
    Nakao S; Arima M; Ishikawa K; Kohno R; Kawahara S; Miyazaki M; Yoshida S; Enaida H; Hafezi-Moghadam A; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4323-8. PubMed ID: 22661475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
    Frenkel MP; Haji SA; Frenkel RE
    Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EFFECT OF INTRAOCULAR PRESSURE-LOWERING MEDICATIONS ON NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATMENT OUTCOMES IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENT TRIALS.
    Rahimy E; Ying GS; Pan W; Hsu J
    Retina; 2019 Apr; 39(4):636-647. PubMed ID: 29517580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of an intravitreal injection of bevacizumab on the expression of VEGF and CD34 in the retina of diabetic rats.
    Ma J; Zhu T; Tang X; Ye P; Zhang Z
    Clin Exp Ophthalmol; 2010 Dec; 38(9):875-84. PubMed ID: 20653693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo release and retinal safety of intravitreal implants of thalidomide in rabbit eyes and antiangiogenic effect on the chorioallantoic membrane.
    Fialho SL; Souza PA; Fulgêncio GO; Miranda MM; Pereira BG; Haddad A; Messias A; Jorge R; Silva-Cunha A
    J Drug Target; 2013 Nov; 21(9):837-45. PubMed ID: 23952807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute vision loss associated with retinal circulatory disturbances after intravitreal injection of bevacizumab.
    Jo YJ; Min JK; Woo JM; Yim JH
    J Ocul Pharmacol Ther; 2013 Feb; 29(1):79-83. PubMed ID: 22663544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of ocular rigidity with intraocular pressure spike after intravitreal injection of bevacizumab in exudative retinal disease.
    Sayah DN; Szigiato AA; Mazzaferri J; Descovich D; Duval R; Rezende FA; Costantino S; Lesk MR
    Br J Ophthalmol; 2021 Mar; 105(3):392-396. PubMed ID: 32345604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intravitreal bevacizumab on macular thickness: exploring serum and vitreous proangiogenic biomarkers in patients with diabetic macular edema.
    Malik TG; Ahmed SS; Gul R; Khalil M; Malik AA; Khan M
    Turk J Med Sci; 2018 Aug; 48(4):833-839. PubMed ID: 30119160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of bevacizumab (Avastin®) on the electroretinogram of isolated rat retina.
    Cia D; Cluzel J; Jacquemot N; Doly M
    Ophthalmic Res; 2011; 46(3):145-51. PubMed ID: 21372616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis.
    Ba J; Peng RS; Xu D; Li YH; Shi H; Wang Q; Yu J
    Drug Des Devel Ther; 2015; 9():5397-405. PubMed ID: 26451092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
    Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
    Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusion.
    Pfau M; Fassnacht-Riederle H; Becker MD; Graf N; Michels S
    Ophthalmic Res; 2015; 54(3):150-6. PubMed ID: 26413794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Late and sustained intraocular pressure elevation related to intravitreal anti-VEGF injections: Cases requiring filtering surgery (French translation of the article)].
    Leleu I; Penaud B; Blumen-Ohana E; Rodallec T; Adam R; Laplace O; Akesbi J; Nordmann JP
    J Fr Ophtalmol; 2018 Nov; 41(9):789-801. PubMed ID: 30348599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theoretical Insights into the Retinal Dynamics of Vascular Endothelial Growth Factor in Patients Treated with Ranibizumab, Based on an Ocular Pharmacokinetic/Pharmacodynamic Model.
    Hutton-Smith LA; Gaffney EA; Byrne HM; Caruso A; Maini PK; Mazer NA
    Mol Pharm; 2018 Jul; 15(7):2770-2784. PubMed ID: 29734810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of bevacizumab treatment in a rat model of retinal ischemia and perfusion injury.
    Kohen MC; Tatlipinar S; Cumbul A; Uslu Ü
    Mol Vis; 2018; 24():239-250. PubMed ID: 29681725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of anti-VEGF antibody on retinal ganglion cells in rats.
    Iriyama A; Chen YN; Tamaki Y; Yanagi Y
    Br J Ophthalmol; 2007 Sep; 91(9):1230-3. PubMed ID: 17475701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Effects of a Novel Phenylphthalimide Analog for Corneal Neovascularization and Retinal Vascular Leakage.
    Wang B; Li PK; Ma JX; Chen D
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3630-3642. PubMed ID: 30029250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
    Ishibashi S; Tawara A; Sohma R; Kubota T; Toh N
    Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.